Monitoring: The hematologic malignancies unfortunately cannot be prevented, but monitoring is extremely relevant, not only for the potential cancer but also for the fairly common myelopathy. This infection is extremely prevalent globally, and treatments like Mogamulizumab continue to be developed for this infectious agent.
Answered 5/17/2017
694 views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question